BRASART HCT 160 MG + 12,5 MG COM REV CT BL AL AL X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1356907320155 -
GGREM
531619010085603 -
Código de barras
7894916512497
O que a fonte publica
- Detentor do registro
- EMS SIGMA PHARMA LTDA
- Princípios ativos
- HIDROCLOROTIAZIDA;VALSARTANA
- Embalagem
- 160 MG + 12,5 MG COM REV CT BL AL AL X 60
- Tipo de produto
- Similar
- Classe terapêutica
- C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "BRASART HCT 160 MG + 12,5 MG COM REV CT BL AL AL X 60",
"holder": "EMS SIGMA PHARMA LTDA",
"stripe": null,
"barcodes": [
"7894916512497"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "531619010085603",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "00.923.140/0001-31",
"priceRegime": "Regulado",
"productName": "BRASART HCT",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "160 MG + 12,5 MG COM REV CT BL AL AL X 60",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "214.06",
"icms-12": "243.25",
"icms-17": "257.90",
"icms-18": "261.05",
"icms-19": "264.27",
"icms-20": "267.58",
"icms-21": "270.96",
"icms-22": "274.44",
"icms-23": "278.00",
"icms-17.5": "259.47",
"icms-19.5": "265.91",
"icms-20.5": "269.26",
"icms-22.5": "276.21",
"icms-12-alc": "240.33",
"icms-17-alc": "254.81",
"icms-18-alc": "257.92",
"icms-19-alc": "261.10",
"icms-20-alc": "264.36",
"icms-21-alc": "267.71",
"icms-22-alc": "271.14",
"icms-23-alc": "274.66",
"withoutTaxes": "211.49",
"icms-17.5-alc": "256.35",
"icms-19.5-alc": "262.72",
"icms-20.5-alc": "266.03",
"icms-22.5-alc": "272.89"
},
"pisCofinsList": "Positiva",
"substanceText": "HIDROCLOROTIAZIDA;VALSARTANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "295.06",
"icms-12": "335.29",
"icms-17": "355.49",
"icms-18": "359.83",
"icms-19": "364.27",
"icms-20": "368.83",
"icms-21": "373.49",
"icms-22": "378.29",
"icms-23": "383.19",
"icms-17.5": "357.65",
"icms-19.5": "366.53",
"icms-20.5": "371.15",
"icms-22.5": "380.73",
"icms-12-alc": "332.24",
"icms-17-alc": "352.26",
"icms-18-alc": "356.56",
"icms-19-alc": "360.96",
"icms-20-alc": "365.46",
"icms-21-alc": "370.09",
"icms-22-alc": "374.84",
"icms-23-alc": "379.70",
"withoutTaxes": "292.37",
"icms-17.5-alc": "354.39",
"icms-19.5-alc": "363.19",
"icms-20.5-alc": "367.77",
"icms-22.5-alc": "377.25"
},
"invalidBarcodes": [],
"activeSubstances": [
"HIDROCLOROTIAZIDA",
"VALSARTANA"
],
"therapeuticClass": "C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1356907320155",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "C9D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:531619010085603"